- Home
- ADXN vs ICCT Comparison
ADXN vs ICCT Comparison
Compare ADXN & ICCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADXN
- ICCT
- Stock Information
- Founded
- ADXN 2002
- ICCT 1992
- Country
- ADXN Switzerland
- ICCT United States
- Employees
- ADXN N/A
- ICCT N/A
- Industry
- ADXN Biotechnology: Pharmaceutical Preparations
- ICCT Computer Software: Prepackaged Software
- Sector
- ADXN Health Care
- ICCT Technology
- Exchange
- ADXN Nasdaq
- ICCT Nasdaq
- Market Cap
- ADXN 11.3M
- ICCT 5.2M
- IPO Year
- ADXN N/A
- ICCT N/A
- Fundamental
- Price
- ADXN $10.30
- ICCT $0.28
- Analyst Decision
- ADXN Strong Buy
- ICCT
- Analyst Count
- ADXN 1
- ICCT 0
- Target Price
- ADXN $30.00
- ICCT N/A
- AVG Volume (30 Days)
- ADXN 22.8K
- ICCT 5.8M
- Earning Date
- ADXN 11-11-2024
- ICCT 11-18-2024
- Dividend Yield
- ADXN N/A
- ICCT N/A
- EPS Growth
- ADXN N/A
- ICCT N/A
- EPS
- ADXN 0.05
- ICCT N/A
- Revenue
- ADXN $960,641.00
- ICCT $10,266,331.00
- Revenue This Year
- ADXN N/A
- ICCT N/A
- Revenue Next Year
- ADXN N/A
- ICCT N/A
- P/E Ratio
- ADXN $1.75
- ICCT N/A
- Revenue Growth
- ADXN N/A
- ICCT 34.56
- 52 Week Low
- ADXN $5.00
- ICCT $0.25
- 52 Week High
- ADXN $27.90
- ICCT $3.20
- Technical
- Relative Strength Index (RSI)
- ADXN 54.08
- ICCT 35.30
- Support Level
- ADXN $10.04
- ICCT $0.34
- Resistance Level
- ADXN $10.81
- ICCT $0.37
- Average True Range (ATR)
- ADXN 0.59
- ICCT 0.07
- MACD
- ADXN 0.04
- ICCT -0.00
- Stochastic Oscillator
- ADXN 70.88
- ICCT 5.67
About ADXN Addex Therapeutics Ltd
Addex Therapeutics Ltd is a clinical stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment which is the discovery, development and commercialization of small-molecule pharmaceutical products.
About ICCT iCoreConnect Inc. Common stock
iCoreConnect Inc develops and markets secure cloud-based HIPAA compliant software services focused on compliance, workflow/productivity, and electronic health records systems. Its core services technology can be adopted to other vertical markets that require a high degree of secure data communication, such as the legal, financial, and education fields. It markets secure HIPAA compliant cloud-based software as a service (SaaS) offering under the names of iCoreExchange, iCoreCodeGenius, iCoreSecure, iCoreMD, iCoreDental, iCoreMobile, iCoreHuddle, iCoreRx, iCorePDMP, iCoreEPCS, and iCorePay. The company's software is sold under annual recurring revenue subscriptions. The company has a single reporting segment for reporting purposes focused on the North American market.